128 related articles for article (PubMed ID: 7735739)
1. Dual contrast magnetic resonance imaging with combined use of positive and negative contrast agent in human hepatocellular carcinoma.
Suto Y; Shimatani Y
Br J Radiol; 1995 Feb; 68(806):116-20. PubMed ID: 7735739
[TBL] [Abstract][Full Text] [Related]
2. Double contrast MR imaging with iron colloid and Gd-DTPA in cholangiocellular carcinoma.
Suto Y; Shimatani Y; Kato T; Kamba M; Ohuchi Y; Kodama F; Kato T; Ohta Y
Acta Radiol; 1994 Nov; 35(6):632-3. PubMed ID: 7946691
[TBL] [Abstract][Full Text] [Related]
3. Time-course changes of contrast enhancement in iron colloid enhanced MRI in patients with hepatocellular carcinoma.
Suto Y; Ametani M; Kamba M; Sugihara S
Br J Radiol; 1996 Mar; 69(819):201-5. PubMed ID: 8800862
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
Zhang HM; Ouyang H; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
[TBL] [Abstract][Full Text] [Related]
6. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
7. Chondroitin sulfate iron colloid-enhanced MR imaging in patients with hepatocellular carcinoma. Comparison with CT during arterial portography.
Kamba M; Suto Y; Kato T
Acta Radiol; 1994 Nov; 35(6):570-5. PubMed ID: 7946680
[TBL] [Abstract][Full Text] [Related]
8. Chondroitin sulfate iron colloid as MR contrast agent in differentiation between hepatocellular carcinoma and adenomatous hyperplasia.
Suto Y; Kato T; Matsuo T; Kamba M; Shimatani Y; Ohuchi Y; Nakamura K; Ohta Y
Acta Radiol; 1993 May; 34(3):226-9. PubMed ID: 8387803
[TBL] [Abstract][Full Text] [Related]
9. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
10. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
Peterson MS; Baron RL; Murakami T
Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
[No Abstract] [Full Text] [Related]
12. Optimum conditions for iron colloid enhanced fast spin echo imaging in hepatocellular carcinoma.
Sugihara S; Suto Y; Yoshida K
Br J Radiol; 1997 Aug; 70(836):791-7. PubMed ID: 9486042
[TBL] [Abstract][Full Text] [Related]
13. Correlation between chondroitin sulfate iron colloid-enhanced MR imaging and the histological grade of hepatocellular carcinoma.
Suto Y; Kodama F; Kamba M; Ohta Y
Acta Radiol; 1995 Jan; 36(1):102-5. PubMed ID: 7833161
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat.
Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J
Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496
[TBL] [Abstract][Full Text] [Related]
15. A study of chondroitin sulfate iron colloid as a liver specific MR contrast agent.
Hussain MZ; Ohtomo K; Kachi K; Uchiyama G; Itai Y
Radiat Med; 1994; 12(1):1-5. PubMed ID: 8016397
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging in the detection of focal liver lesions: comparison of dynamic contrast-enhanced TurboFLASH and T2 weighted spin echo images.
Ward J; Baudouin CJ; Ridgway JP; Robinson PJ
Br J Radiol; 1995 May; 68(809):463-70. PubMed ID: 7788230
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging.
Murakami T; Nakamura H; Tsuda K; Nakanishi K; Hori S; Tomoda K; Mitani T; Kozuka T; Monden M; Wakasa K
AJR Am J Roentgenol; 1993 Feb; 160(2):295-9. PubMed ID: 8380948
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
19. Small hepatocellular carcinoma on magnetic resonance imaging. Relation of signal intensity to angiographic and clinicopathologic findings.
Honda H; Kaneko K; Maeda T; Kuroiwa T; Fukuya T; Yoshimitsu K; Irie H; Aibe H; Takenaka K; Masuda K
Invest Radiol; 1997 Mar; 32(3):161-8. PubMed ID: 9055129
[TBL] [Abstract][Full Text] [Related]
20. Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging.
Lencioni R; Mascalchi M; Caramella D; Bartolozzi C
Abdom Imaging; 1996; 21(1):41-8. PubMed ID: 8672971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
